Preterm birth. Treatment and evidences

• Autor: Pacheco Romero, José
• Formato: artículo
• Fecha de Publicación: 2015
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista SPOG - Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español
• OAI Identifier: oai:ojs.spog:article/1068
• Enlace del recurso: http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/1068
• Nivel de acceso: acceso abierto

We do a brief account on evidence-based preterm birth treatment, emphasizing the importance of appropriate clinical, ultrasound and laboratory diagnosis. Tocolysis may decrease uterine activity and uterine cervix modifications but does not lower preterm birth rates; it may prolong gestation though to allow corticoids administration and in utero fetus transportation to a specialized unit. If we have to use a tocolytic agent, beta agonists are no longer first line drugs, and atosiban and nifedipine have less adverse maternal effects. A single dose of corticoids between 24 and 34 weeks of gestation reduces preterm death, respiratory distress syndrome and intraventricular hemorrhage risks. Preterm birth is a social problem of major importance and more emphasis should be placed on primary prevention and treatment of immaturity.